Literature DB >> 26723240

Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle.

Jules L Derks1, Ernst-Jan M Speel2, Erik Thunnissen3, Robert Jan van Suylen4, Wieneke A Buikhuisen5, Marie-Louise F van Velthuysen6, Anne-Marie C Dingemans7.   

Abstract

Here we report the case of a pulmonary neuroendocrine tumor (pNET) in which the pathological diagnosis was revised several times over the course of the patient's disease because of atypical behavior of the tumor; consequently, the patient was treated with various treatment schedules.
Copyright © 2015 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical carcinoid; Case report; Diagnosis; LCNEC; Lung

Mesh：

Year:  2015        PMID： 26723240     DOI： 10.1016/j.jtho.2015.10.013

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


  5 in total

1.  Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.

Authors:  Alessandra Fabbri; Mara Cossa; Angelica Sonzogni; Mauro Papotti; Luisella Righi; Gaia Gatti; Patrick Maisonneuve; Barbara Valeri; Ugo Pastorino; Giuseppe Pelosi
Journal:  Virchows Arch       Date:  2017-01-04       Impact factor: 4.064

Review 2.  Classification of pulmonary neuroendocrine tumors: new insights.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Sergio Harari; Adriana Albini; Enrica Bresaola; Caterina Marchiò; Federica Massa; Luisella Righi; Gaia Gatti; Nikolaos Papanikolaou; Namrata Vijayvergia; Fiorella Calabrese; Mauro Papotti
Journal:  Transl Lung Cancer Res       Date:  2017-10

3.  Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept.

Authors:  Giuseppe Pelosi; Federica Massa; Gaia Gatti; Luisella Righi; Marco Volante; Nadia Birocco; Patrick Maisonneuve; Angelica Sonzogni; Sergio Harari; Adriana Albini; Mauro Papotti
Journal:  Clin Pathol       Date:  2019-02-19

4.  Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.

Authors:  Natasha Rekhtman; Patrice Desmeules; Anna M Litvak; Maria C Pietanza; Maria Lauren Santos-Zabala; Ai Ni; Joseph Montecalvo; Jason C Chang; Amanda Beras; Isabel R Preeshagul; Joshua K Sabari; Charles M Rudin; Marc Ladanyi; David S Klimstra; William D Travis; Wei-Chu Lai
Journal:  Mod Pathol       Date:  2019-03-28       Impact factor: 7.842

Review 5.  The Ki-67 antigen in the new 2021 World Health Organization classification of lung neuroendocrine neoplasms.

Authors:  Giuseppe Pelosi; William D Travis
Journal:  Pathologica       Date:  2021-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.